Open fracture of pelvis

description: A traumatic break in one or more of the bones comprising the bony structure of the pelvis that involves a break in the adjacent skin..


Fracture of Skull Related to Birth

category: biolink:PhenotypicFeature biolink:DiseaseOrPhenotypicFeature biolink:BiologicalEntity biolink:ThingWithTaxon biolink:NamedThing

description: An injury sustained during the birthing process in which the continuity is broken in the skull.


Fracture of pelvis

category: biolink:Disease biolink:DiseaseOrPhenotypicFeature biolink:BiologicalEntity biolink:ThingWithTaxon biolink:NamedThing

description: A traumatic break in one or more of the bones that compose the bony structure of the pelvis.


Limb fracture

description: A traumatic break in one or more bones in a limb.


Open fracture of metacarpal bone

description: A traumatic break in one or more of the metacarpal bones that involves a break in the adjacent skin.


Fracture of Nose Related to Birth

description: A broken nasal bone sustained during the birthing process.


Grade 2 Vaginal Hemorrhage, CTCAE

description: Moderate symptoms; intervention indicated


An alkatriene consisting of 4,8-dimethylnonane having the three double bonds in the 1-, 3- and 7-positions.


O-linoleyl-L-carnitine

An O-octadecadienoyl-L-carnitine where the acyl group specified is linoleyl.


A L-tyrosine derivative that is L-dopa in which the hydroxy groups at positions 3 and 4 of the phenyl ring are replaced by methoxy groups.


A mononitroglycerol that is glycerol in which the hydrogen atom of the hydroxy group at position 1 is replaced by a nitro group.


name: EC 3.5.4.4 (adenosine deaminase) inhibitor

description: An EC 3.5.4.* (non-peptide cyclic amidine C-N hydrolase) inhibitor that interferes with the action of adenosine deaminase (EC 3.5.4.4).


Parotid Gland Lymphangioma

description: A lymphangioma arising from the parotid gland.


Eyelid Carcinoma pT4 TNM Finding v8

description: Any eyelid carcinoma invading adjacent ocular, orbital, or facial structures. (from AJCC 8th Ed.)


Eyelid Carcinoma pT4a TNM Finding v8

description: Eyelid carcinoma with tumor invading ocular or intraorbital structures. (from AJCC 8th Ed.)


Eyelid Carcinoma pT4b TNM Finding v8

description: Eyelid carcinoma with tumor invading (or eroding through) the bony walls of the orbit or extending to the paranasal sinuses or invading the lacrimal sac/nasolacrimal duct or brain. (from AJCC 8th Ed.)


PENTAMETHONIUM BROMIDE

The bromide salt of pentamethonium. It is a ganglion blocker and exhibits antihypertensive activity.


A member of the class of  thiadiazoles  that is 1,3,4-thiadiazole substituted by pyrazin-2-yl and (2,6-dichlorobenzyl)sulfanediyl groups at positions 2 and 5, respectively. It is a selective activator of mechanosensitive channel piezo1.


dichlorobenzene

Any member of the class of chlorobenzenes carrying two chloro groups at unspecified positions.


avilamycin A precursor

An oligosaccharide derivative that is produced by Streptomyces viridochromogenes and is an epimeric intermediate in the biosynthesis of avilamycin A.


TEFLUBENZURON

A N-acylurea that is N-carbamoyl-2,6-difluorobenzamide substituted by a 3,5-dichloro-2,4-difluorophenyl group at the terminal nitrogen atom.


(S)-vinclozolin

A 3-(3,5-dichlorophenyl)-5-ethenyl-5-methyl-2,4-oxazolidinedione that is the (S)-enantiomer of vinclozolin.


TESEVATINIB

A member of the class of quinazolines that is quinazoline substituted by (3,4-dichloro-2-fluorophenyl)amino, methoxy, and [(3aR,5r,6aS)-2-methyloctahydrocyclopenta[c]pyrrol-5-yl]methoxy groups at positions 4, 6 and 7, respectively. It is a multi-target tyrosine kinase inhibitor of EGFR, ErbB2, KDR, Flt4 and EphB4 and exhibits anti-cancer properties.


(R)-piperalin

A 3-(2-methylpiperidin-1-yl)propyl 3,4-dichlorobenzoate that has R configuration.


ISOCONAZOLE

A member of the class of imidazoles that carries a 2-[(2,6-dichlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl group at position 1.


(S)-fenticonazole

A 1-[2-(2,4-dichlorophenyl)-2-{[4-(phenylsulfanyl)benzyl]oxy}ethyl]imidazole that is the (S)-enantiomer of fenticonazole.


An organochlorine compound that is the 3'-hydroxylated metabolite of diclofenac.


A member of the class of isoxazoles that is 4,5-dihydro-1,2-oxazole substituted by 4-[(2-ethyl-3-oxo-1,2-oxazolidin-4-yl)carbamoyl]-3-methylphenyl, trifluoromethyl, and 3,5-dichloro-4-fluorophenyl groups at positions 3, 5, and 5, respectively.


(S)-piperalin

A 3-(2-methylpiperidin-1-yl)propyl 3,4-dichlorobenzoate that has S configuration.


The (4S,5S)-stereoisomer of isocycloseram.


A monocarboxylic acid that is cyclopropanecarboxylic acid substituted by methyl groups at positions 1 and 2 and a 3,5-dichlorophenylcarbamoyl group at position 2.


A trichlorobiphenyl that is 1,4-dichlorobenzene in which one of the hydrogens has been replaced by a 3-chlorophenyl group.


dichlorobenzoyl-CoA

Any  chlorobenzoyl-CoA having dichlorobenzoyl as the aroyl substituent.


A phenylurea that is urea substituted by 4-chloro-2-hydroxyphenyl and 3,4-dichlorophenyl groups at positions 1 and 3 respectively. A metabolite of triclocarban.


FLUQUINCONAZOLE

A member of the class of quinazolines that is 6-fluoroquinazolin-4-one carrying additional 1,2,4-triazol-1-yl and 2,4-dichlorophenyl substituents at positions 2 and 3 respectively. A fungicide used to control Ascomycetes, Deuteromycetes and Basidiomycetes spp. on cereals, beets and fruit.


A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 2-cyano-3,3-dimethylbutanoic acid with the amino group of 1-(2,4-dichlorophenyl)ethylamine.


dichlorocatechol

A chlorocatechol carrying two chloro groups at unspecified positions.


(S)-flufiprole

A 1-[2,6-dichloro-4-(trifluoromethyl)phenyl]-5-[(2-methylprop-2-en-1-yl)amino]-4-[(trifluoromethyl)sulfinyl]-1H-pyrazole-3-carbonitrile that has S configuration at the sulfoxide.


A member of the class of  benzamides that is benzamide substituted by chloro groups at positions 2 and 6.


GAMENDAZOLE

A member of the class of indazoles that is 3-(indazol-3-yl}prop-2-enoic acid carrying additional 2,4-dichlorobenzyl and trifluoromethyl substituents at positions 1 and 6 respectively. An orally active antispermatogenic compound with antifertility effects that is a potential male contraceptive drug.


A member of the class of  benzamides that is obtained by the formal condensation of  2,4-dichlorobenzoic acid and  benzotriazole. It acts as an inhibitor for tubulin acetylation mediated by trichostatin A.


(S)-fipronil

A 5-amino-1-[2,6-dichloro-4-(trifluoromethyl)phenyl]-4-[(trifluoromethyl)sulfinyl]-1H-pyrazole-3-carbonitrile that has S configuration at the sulfoxide.


An organochlorine compound that is a metabolite of diclofenac having hydroxy and methoxy groups at positions 3' and 4' respectively..


diclofenac beta-D-glucosiduronic acid

A beta-D-glucosiduronic acid (beta-D-glucuronide) that is a metabolite of diclofenac.


RAC-DICHLORPROP

An aromatic ether that is 2-hydroxypropanoic acid in which the hydroxy group at position 2 has been converted to its 2,4-dichlorophenyl ether.


CHLOZOLINATE

A racemate comprising equimolar amounts of (R)- and (S)-chlozolinate. An obsolete fungicide, formerly used as a foliar spray against Botrytis, Sclerotinia and Monilia spp.


dichlorobenzyl alcohol

A member of the class of benzyl alcohols that is benzyl alcohol in which the hydrogens at positions 2 and 4 are replaced by chlorines.


(S)-DICHLORPROP

The S- (inactive) enantiomer of dichlorprop.


(S)-chlozolinate

An ethyl 3-(3,5-dichlorophenyl)-5-methyl-2,4-dioxo-1,3-oxazolidine-5-carboxylate that is the (S)-enantiomer of chlozolinate.


(R)-fipronil

A 5-amino-1-[2,6-dichloro-4-(trifluoromethyl)phenyl]-4-[(trifluoromethyl)sulfinyl]-1H-pyrazole-3-carbonitrile that has R configuration at the sulfoxide.


(S)-econazole

A 1-{2-(4-chlorobenzyloxy)-2-(2,4-dichlorophenyl)ethyl}imidazole that is the (S)-enantiomer of econazole.


A dichlorocatechol that is catechol in which the hydrogens at positions 3 and 4 are replaced by chlorines.


An alanine derivative that is methyl 3-[2-(2,6-dichlorophenyl)quinolin-6-yl]alaninate in which one of the hydrogens attached to the primary amino group is replaced by a 2,6-dichlorobenzyl group.


The (4R,5S)-stereoisomer of isocycloseram.


(R)-zoxamide

A 3,5-dichloro-N-(1-chloro-3-methyl-2-oxopentan-3-yl)-4-methylbenzamide that is the (R)-enantiomer of zoxamide.


AZACONAZOLE

A member of the class of dioxolanes that is 1,3-dioxolane substituted at position 2 by 2,4-dichlorophenyl and 1,2,4-triazol-1-ylmethyl groups. A fungicide used mainly in ornamental crops to control canker and other diseases. Azaconazole is moderately toxic to mammals but is not expected to bioaccumulate. It is moderately toxic to birds, fish and aquatic invertebrates.


(S)-zoxamide

A 3,5-dichloro-N-(1-chloro-3-methyl-2-oxopentan-3-yl)-4-methylbenzamide that is the (S)-enantiomer of zoxamide.


A member of the class of ureas that is  1-methylurea substituted by a hydroxy group at position 1 and a 3,4-dichlorophenyl group at position 3.


bixlozone

An isoxazolidinone that is 1,2-oxazolidin-3-one substituted by a 2,4-dichlorobenzyl group at position 2 and two methyl groups at position 4. It is a herbicide used for the control of annual ryegrass (including herbicide resistant biotypes) and regionally specific broadleaf weeds.


A non-proteinogenic amino acid derivative that is methyl alaninate substituted by a tert-butoxycarbonyl group the primary amino group and by a 2-(2,6-dichlorophenyl)-6-quinolyl group at position 3.


A phenylurea that is urea substituted by 4-chloro-2-sulfooxyphenyl and 3,4-dichlorophenyl groups at positions 1 and 3 respectively. A metabolite of triclocarban.


(S)-mefenpyr

A 1-(2,4-dichlorophenyl)-5-methyl-4,5-dihydro-1H-pyrazole-3,5-dicarboxylic acid that has S configuration.


The stereoisomer of 2-cyano-N-[1-(2,4-dichlorophenyl)ethyl]-3,3-dimethylbutanamide obtained by formal condensation of the carboxy group of (S)-2-cyano-3,3-dimethylbutanoic acid with the amino group of (R)-1-(2,4-dichlorophenyl)ethylamine.


(S)-leptophos

The (S)-enantiomer of leptophos.


A member of the class of imines that is 2,3-dihydro-1,4-naphthoquinone imine in which the imine hydrogen has been replaced by a 3,5-dichloro-4-hydroxyphenyl group.


(S)-butoconazole

The (S)-enantiomer of butoconazole.


A dichlorobiphenyl that is 1,3-dichlorobenzene in which the hydrogen at position 2 is replaced by a phenyl group.


ixazomib

A glycine derivative that is the amide obtained by formal condensation of the carboxy group of N-(2,5-dichlorobenzoyl)glycine with the amino group of [(1R)-1-amino-3-methylbutyl]boronic acid. The active metabolite of ixazomib citrate, it is used in combination therapy for treatment of multiple myeloma.


An member of the class of biphenyls that is 2,2',5,5'-tetrachlorobiphenyl in which the 4 and 4' positions are substituted by methylsulfonyl groups.


name: 4-(2,4-dichlorophenoxy)butanoic acid [2-oxo-2-[(phenylmethyl)amino]ethyl] ester


(S)-sulconazole

A 1-{2-[(4-chlorobenzyl)sulfanyl]-2-(2,4-dichlorophenyl)ethyl}-1H-imidazole that has S configuration.


IXAZOMIB CITRATE

A glycine derivative that is the amide obtained by formal condensation of the carboxy group of N-(2,5-dichlorobenzoyl)glycine with the amino group of 2,2'-{2-[(1R)-1-amino-3-methylbutyl]-5-oxo-1,3,2-dioxaborolane-4,4-diyl}diacetic acid. A prodrug for ixazomib that is used in combination therapy for treatment of multiple myeloma.


A member of the class of hydroxybiphenyls that is biphenyl-4-ol with chlorine atoms substituted at positions 2 and 6.


vilanterol

An dichlorobenzene derivative that is used in the form of its trifenate salt for treatment of chronic obstructive pulmonary disease.


linkable PD173955 analogue

An analogue of PD173955 where the methylmercapto group is replaced by aminomethyl.


FENPICLONIL

A member of the class of pyrroles carrying cyano and 2,3-dichlorophenyl substituents at positions 3 and 4 respectively. A fungicide used mainly to control seed-borne pathogens in cereal crops.


N-(3,4-dichlorophenyl)malonamic acid

A dicarboxylic acid monoamide that is the mono-(3,4-dichloroanilide) of malonic acid.


FENOXASULFONE

A dichlorobenzene that is benzene in which the hydrogens at positions 1, 2, 4 and 5 are replaced by [(5,5-dimethyl-4,5-dihydro-1,2-oxazol-3-yl)sulfonyl]methyl, chloro, ethoxy and chloro groups, respectively. It is a rice herbicide developed by Kumiai Chemical Industry Co. Ltd which displays excellent herbicidal activity against Echinochloa spp. and other annual weeds.


(R)-diclofop-methyl

A methyl 2-[4-(2,4-dichlorophenoxy)phenoxy]propanoate that is the (R)-enantiomer of diclofop-methyl.


A member of the class of piperidines that is 2-methylpiperidine in which the hydrogen attached to the nitrogen is replaced by a 3-[(3,4-dichlorobenzoyl)oxy]propyl group.


fenticonazole

A racemate comprising equimolar amounts of (R)- and (S)-fenticonazole. Used (as its nitrate salt) for the treatment of vaginal candidiasis.


(S)-tioconazole

A 1-{2-[(2-chloro-3-thienyl)methoxy]-2-(2,4-dichlorophenyl)ethyl}imidazole that is the (S)-enantiomer of tioconazole.


A methyl ketone resulting from the formal hydration of the ethynyl group of the herbicide propyzamide. It is a major soil metabolite of propyzamide.


ETACONAZOLE

A member of the class of dioxolanes that is 1,3-dioxolane substituted at position 2 by 2,4-dichlorophenyl and 1,2,4-triazol-1-ylmethyl groups and at position 4 by an ethyl group. An obsolete fungicide that was used to control powdery mildew on fruit and other crops.


diclomezine

A pyridazinone that is pyridazin-3(2H)-one which is substituted at position 6 by a 3,5-dichloro-4-methylphenyl group. A fugicide, it is used to treat rice sheath blight caused by Rhizoctonia solani.


isoconazole

A racemate comprising equimolar amounts of (R)- and (S)-isoconazole. A broad-spectrum antibacterial drug used (as its nitrate salt) for treatment of dermatomycoses.


A member of the class of pyrazoles that is 1-(2,6-dichlorophenyl)-1H-pyrazole which is substituted by a difluoromethyl group at position 3 and by a 2-(isobutyrylamino)-1,3-thiazol-5-yl group at position 5. It is a a potent cell-permeable inhibitor of LIM kinase 1 and 2.


pyrifenox

An oxime O-ether that is the O-methyloxime of 2',4'-dichloro-2-(3-pyridyl)acetophenone.  A fungicide used for control of powdery mildew, scab and other fungal pathogens on a range of crops.


JTE-607 free base

A secondary carboxamide resulting from the formal condensation of the carboxy group of 3,5-dichloro-2-hydroxy-4-[2-(4-methylpiperazin-1-yl)ethoxy]benzoic acid with the amino group of ethyl L-phenylalaninate. It inhibits cytokine production in human peripheral blood mononuclear cells (PBMC's) without causing immunosuppression.


A tertiary carboxamide that is piperazine in which one of the amino groups has undergone condensation with the carboxy group of N-[(2,4-dichlorophenyl)sulfonyl]-L-serine, while the other has undergone condensation with the carboxy group of N-(1-benzothiophen-2-ylcarbonyl)-L-leucine. It is a cell-permeable, potent and selective agonist of the TRPV4 (transient receptor potential vanilloid 4) channel.


A leucine derivative obtained by fpormal condensation of the secondary amino group of 5-({2,3-dichloro-4-[1-methyl-5-(piperidin-4-yl)-1H-pyrazol-3-yl]phenoxy}methyl)-2-furoic acid and the carboxy group of N-amidino-L-leucylglycine


A dichlorocatechol carrying chloro groups at positions 3 and 5.


(R)-econazole

A 1-{2-(4-chlorobenzyloxy)-2-(2,4-dichlorophenyl)ethyl}imidazole that is the (R)-enantiomer of econazole.


A non-proteinogenic amino acid derivative that is the methyl ester of N-(2,6-dichlorobenzoyl)-3-(2-phenoxy-6-quinolyl)alanine.


fluopicolide

A member of the class of benzamides obtained by formal condensation of the carboxy group of 2,6-dichlorobenzoic acid with the amino group of [3-chloro-5-(trifluoromethyl)pyridin-2-yl]methylamine. A fungicide used for the control of a range of diseases including downy mildew and blight.


(R)-diclofop

A 2-[4-(2,4-dichlorophenoxy)phenoxy]propanoic acid that is the (R)-enantiomer of diclofop.


A member of the class of pyrazoles that is 4,5-dihydro-1H-pyrazole substituted by a 2,4-dichlorophenyl group, carboxy group, carboxy group and methyl group at positions 1,3,5 and 5, respectively.


(R)-chlozolinate

An ethyl 3-(3,5-dichlorophenyl)-5-methyl-2,4-dioxo-1,3-oxazolidine-5-carboxylate that is the (R)-enantiomer of chlozolinate.


2,4-dichlorobenzoic acid

A chlorobenzoic acid that is benzoic acid in which the ring hydrogens at positions 2 and 4 are substituted by chloro groups.


(R,R)-fenoxanil

The stereoisomer of N-(2-cyano-3-methylbutan-2-yl)-2-(2,4-dichlorophenoxy)propanamide obtained by formal condensation of the carboxy group of (R)-2-(2,4-dichlorophenoxy)propanoic acid with the amino group of (R)-2-amino-2,3-dimethylbutanenitrile.


A chloroamino acid that is L-tyrosine carrying chloro- substituents at positions C-3 and C-5 of the benzyl group.


dichlorohydroquinone

A member of the class of  chlorohydroquinones carrying two chloro substituents at unspecified positions.


DICLOFOP

An aromatic ether that is 2-(4-hydroxyphenoxy)propanoic acid in which the hydrogen of the hydroxy group at position 4 has been substituted by a 2,4-dichlorophenyl group.


name: 2-[[5-(2,4-dichlorophenyl)-1,3,4-oxadiazol-2-yl]thio]acetic acid ethyl ester


lorglumide

A dicarboxylic acid monoamide obtained by formal condensation of the alpha-carboxy group of N-(3,4-dichlorobenzoyl)glutamic acid with the amino group of dipentylamine.


(S,S)-cyclobutrifluram

A N-[2-(2,4-dichlorophenyl)cyclobutyl]-2-(trifluoromethyl)pyridine-3-carboxamide that has 1S,2S-configuration.


2,5-dichlorobenzoic acid

A chlorobenzoic acid that is benzoic acid in which the ring hydrogens at positions 2 and 5 are substituted by chloro groups.


A tetrachlorobiphenyl that is biphenyl in which each of the phenyl groups is substituted at positions 2 and 4 by chlorines.


dichlorophenol

Any chlorophenol carrying chloro substituents.


diclofenamide

A sulfonamide that is benzene-1,3-disulfonamide in which the hydrogens at positions 4 and 5 are substituted by chlorine. An oral carbonic anhydrase inhibitor, it partially suppresses the secretion (inflow) of aqueous humor in the eye and so reduces intraocular pressure. It is used for the treatment of glaucoma.


A member of the class of  benzamides obtained by the formal condensation of 1H-benzimidazole and  2,4-dichlorobenzoic acid.


(S,R)-fenoxanil

The stereoisomer of N-(2-cyano-3-methylbutan-2-yl)-2-(2,4-dichlorophenoxy)propanamide obtained by formal condensation of the carboxy group of (S)-2-(2,4-dichlorophenoxy)propanoic acid with the amino group of (R)-2-amino-2,3-dimethylbutanenitrile.


(R)-vinclozolin

A 3-(3,5-dichlorophenyl)-5-ethenyl-5-methyl-2,4-oxazolidinedione that is the (R)-enantiomer of vinclozolin.


An N-acyl amino acid that is N-(2,6-dichlorobenzoyl)alanine in which one of the hydrogens at the beta position has been replaced by a  N 6-(2,6-dimethoxyphenyl)-2-naphthyl group.


3,5-dichlorobenzoic acid

A chlorobenzoic acid that is benzoic acid in which the ring hydrogens at positions 3 and 5 are substituted by chloro groups.


(S,S)-fenoxanil

The stereoisomer of N-(2-cyano-3-methylbutan-2-yl)-2-(2,4-dichlorophenoxy)propanamide obtained by formal condensation of the carboxy group of (S)-2-(2,4-dichlorophenoxy)propanoic acid with the amino group of (S)-2-amino-2,3-dimethylbutanenitrile.


(S)-isoconazole

A 1-{2-[(2,6-dichlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl}imidazole that is the (S)-enantiomer of isoconazole.


A non-proteinogenic amino acid derivative that is the methyl ester of N-(2,6-dichlorobenzyl)-3-[2-(2,6-dichlorophenyl)-6-quinolyl]-N-methylalanine.


(R)-fenticonazole

A 1-[2-(2,4-dichlorophenyl)-2-{[4-(phenylsulfanyl)benzyl]oxy}ethyl]imidazole that is the (R)-enantiomer of fenticonazole.


2,6-dichlorobenzoic acid

A chlorobenzoic acid carrying two chloro groups at positions 2 and 6 respectively.


2,3-dichlorobenzoic acid

A chlorobenzoic acid that is benzoic acid in which the ring hydrogens at positions 2 and 3 are substituted by chloro groups.


(S)-triarimol

A (2,4-dichlorophenyl)(phenyl)pyrimidin-5-ylmethanol that has S configuration.


(S)-miconazole

A 1-[2-(2,4-dichlorobenzyloxy)-2-(2,4-dichlorophenyl)ethyl]imidazole that has S) configuration.


neflamapimod

A member of the class of pyrimidopyridazines that is 6H-pyrimido[1,6-b]pyridazin-6-one substituted at positions 2 and 5 by (2,4-difluorophenyl)sulfanyl and 2,6-dichlorophenyl groups respectively


dicloromezotiaz

A pyridopyrimidine that is 9-methyl-2,4-dioxo-2H-pyrido[1,2-a]pyrimidine substituted at positions 1 and 3 by (2-chloro-1,3-thiazol-5-yl)methyl and 3,5-dichlorophenyl groups respectively. A mesoionic insecticide used for control of rice hoppers.


tioconazole

A member of the class of imidazoles that comprises 2-(2,4-dichlorophenyl)ethylimidazole carrying an additional (2-chloro-3-thienyl)methoxy substituent at position 2.


bixafen

An aromatic amide obtained by formal condensation of the carboxy group of 3-(difluoromethyl)-1-methylpyrazole-4-carboxylic acid with the amino group of 3',4'-dichloro-5-fluorobiphenyl-2-amine. A fungicide for use in cereals for key stem and leaf disease control including strobilurin-resistant septoria.


diuron-desdimethyl

A member of the class of ureas that is urea substituted by a 3,4-dichlorophenyl group at position 1. It is a metabolite of the herbicide diuron.


name: N-[2-cyano-3-(2,4-dichloroanilino)-1-oxoprop-2-enyl]carbamic acid ethyl ester


name: 2-[[5-(2,4-dichlorophenyl)-1,3,4-oxadiazol-2-yl]thio]acetic acid butyl ester


fipronil-desulfinyl

A member of the class of pyrazoles that is 1H-pyrazole that is substituted at positions 1, 3, 4, and 5 by 2,6-dichloro-4-(trifluoromethyl)phenyl, cyano, trifluoromethyl, and amino groups, respectively.


(R)-flufiprole

A 1-[2,6-dichloro-4-(trifluoromethyl)phenyl]-5-[(2-methylprop-2-en-1-yl)amino]-4-[(trifluoromethyl)sulfinyl]-1H-pyrazole-3-carbonitrile that has R configuration at the sulfoxide.


A member of the class of phenylacetic acids that is phenylacetic acid having a (2,6-dichlorophenyl)amino group at the 2-position and a 2-(2-oxoethoxy)ethoxy group at the 5-position.


imibenconazole

A member of the class of imidothioates that is the S-4-chlorobenzyl thioester of N-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-yl)ethanimidothioic acid. Used to control a range of fungal diseases affecting fruit, vegetables, turf and ornamentals. It has a low mammalian toxicity and shows a moderate level of toxicity to fish, daphnia and earthworms but is relatively non-toxic to honey bees, birds and algae.


N-acetyldichloro-L-tyrosine

An L-tyrosine derivative in which an L-tyrosine core has two chloro substituents at each position ortho to the benzyl hydroxy group and an acetyl substituent on the nitrogen atom.


A member of the class of pryrazoles that is 4-amino-1H-pyrazole-3-carboxylic acid in which the primary amino group has been acylated by a 2,6-dichlorobenzoyl group and in which the carboxylic acid has been converted into a carboxamide by formal condensation with the primary amino group of 4-aminopiperidine.


A member of the class of indolones that is 1,3-dihydro-2H-indol-2-one which is substituted by a (2,6-dichlorobenzyl)sulfonyl group at position 5 and by a (1H-pyrrol-2-yl)methylidene group at position 2, the pyrrole ring of which is substituted by methyl groups at positions 3 and 5, and by a [2-(pyrrolidin-1-ylmethyl)pyrrolidin-1-yl]carbonyl group at position 4 (the Z,R isomer).


acetoprole

A phenylpyrazole insecticide that is 3-acetyl-1H-pyralole which is substituted at positions 1, 4, and 5 by 2,6-dichloro-4-(trifluoromethyl)phenyl, methylsulfinyl, and amino groups, respectively. A GABA-gated chloride channel antagonist, it was formerly used as an insecticide and acaricide for the control of sucking and chewing insect pests.


diniconazole-M

A (1E)-1-(2,4-dichlorophenyl)-4,4-dimethyl-2-(1,2,4-triazol-1-yl)pent-1-en-3-ol that is the active R-enantiomer of diniconazole. A fungicide used to control a range of diseases including mildew, bunts and smuts.


A dichlorophenol in which the two chloro substituents are located at positions 3 and 5.


BUTENE-FIPRONIL

A member of the class of pyrazoles that is 1H-pyrazole that is substituted at positions 1, 3, 4, and 5 by 2,6-dichloro-4-(trifluoromethyl)phenyl, cyano, (trifluoromethyl)sulfinyl, and (2-methylprop-2-en-1-yl)nitrilo groups, respectively.


fenoxanil

A four component diastereoisomeric mixture composed of the diastereomeric pair (R,R)- and (R,S)-fenoxanil in an 85:15 ratio with the diastereomeric pair (S,R)- and (S,S)-fenoxanil. A fungicide used mainly for control of rice blast.


A monocarboxylic acid that is the 4',5-dihydroxylated metabolite of diclofenac.


diuron-desmethyl

A member of the class of phenylureas that is urea in which a hydrogens attached to one nitrogen is substituted by a methyl group, and one of the hydrogens attached to the other nitrogen is substituted by a 3,4-dichlorophenyl group. It is a metabolite of diuron.


A member of the class of aminopyrimidines that is pyrimidine substituted by {2-[(6-amino-5-nitropyridin-2-yl)amino]ethyl}amino, 2,4-dichlorophenyl, and 1H-imidazol-1-yl groups at positions 2, 4 and 5, respectively. It is a potent ATP-competitive inhibitor of GSK3alpha and GSK3beta (IC50 values of 0.65 and 0.58 nM, respectively).


fenaminstrobin

A monocarboxylic acid amide obtained by formal condensation of the carboxy group of (2E)-{2-[({(E)-[(3E)-4-(2,6-dichlorophenyl)but-3-en-2-ylidene]amino}oxy)methyl]phenyl}(methoxyimino)acetic acid with the amino group of methylamine. A broad-spectrum fungicide.


(S,S)-tubulozole

An ethyl [4-({[2-(2,4-dichlorophenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methyl}sulfanyl)phenyl]carbamate in which both stereocentres have S-configuration.


(R,R)-cyclobutrifluram

A N-[2-(2,4-dichlorophenyl)cyclobutyl]-2-(trifluoromethyl)pyridine-3-carboxamide that has 1R,2R-configuration.


tecloftalam

A dicarboxylic acid monoamide that is the mono-(2,3-dichloroanilide) of tetrachlorophthalic acid. It is used for the treatment of bacterial leaf blight in paddy rice.


(S)-enilconazole

A 1-[2-(allyloxy)-2-(2,4-dichlorophenyl)ethyl]imidazole that is the (S)-enantiomer of enilconazole


A monocarboxylic acid that is the 5-hydroxylated metabolite of diclofenac.


(S)-diclofop

A 2-[4-(2,4-dichlorophenoxy)phenoxy]propanoic acid that is the (S)-enantiomer of diclofop.


(R)-penconazole

A 1-[2-(2,4-dichlorophenyl)pentyl]1,2,4-triazole that is the (R)-enantiomer of penconazole.


(R)-enilconazole

A 1-[2-(allyloxy)-2-(2,4-dichlorophenyl)ethyl]imidazole that is the (R)-enantiomer of enilconazole.


A non-proteinogenic amino acid derivative that is the methyl ester of N-(2,6-dichlorobenzoyl)-3-[2-(2,6-dichlorophenyl)-6-quinolyl]alanine.


ARASERTACONAZOLE

A 1-{2-[(7-chloro-1-benzothiophen-3-yl)methoxy]-2-(2,4-dichlorophenyl)ethyl}imidazole that is the active R-enantiomer of sertaconazole and is used (as its nitrate salt) for treatment of vulvovaginal candidiasis. The racemate itself is also used as a broad-spectrum antifungal drug.


(R)-butaconazole

The (R)-enantiomer of butaconazole.


(R)-MICONAZOLE

A 1-[2-(2,4-dichlorobenzyloxy)-2-(2,4-dichlorophenyl)ethyl]imidazole that has R configuration.


An alanine derivative that is alanine substituted by a 2,6-dichlorobenzoyl group at the N and a 2-(2,6-dichlorophenyl)-6-quinolyl group at position 3.


A member of the class of piperidinylimidazoles that is 1-methyl-4-(1-propylimidazol-2-yl)piperidine carrying additional 3,4-dichlorophenyl and 2-(cyclopropylamino)pyrimidin-4-yl substituents at positions 4 and 5 respectively.


(R)-tioconazole

A 1-{2-[(2-chloro-3-thienyl)methoxy]-2-(2,4-dichlorophenyl)ethyl}imidazole that is the (R)-enantiomer of tioconazole.


A dipeptide comprising of phenylglycine derived residues linked by peptide bonds.


(R)-sulconazole

A 1-{2-[(4-chlorobenzyl)sulfanyl]-2-(2,4-dichlorophenyl)ethyl}-1H-imidazole that has R configuration.


name: N-[2-[5-[(2,4-dichlorophenyl)methylsulfonyl]-1,3,4-oxadiazol-2-yl]ethyl]carbamic acid tert-butyl ester


A dichlorohydroquinone that is hydroquinone substituted by chloro groups at positions 2 and 6.


An N-acyl amino acid that is alanine substituted by a 2,6-dichlorobenzoyl group at the N and a 2-phenoxy-6-quinolyl group at position 3.


(R,R)-tubulozole

An ethyl [4-({[2-(2,4-dichlorophenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methyl}sulfanyl)phenyl]carbamate in which both stereocentres have R-configuration.


methyl 2,5-dichlorobenzoate

A methyl ester resulting from the formal condensation of the carboxy group of 2,5-dichlorobenzoic acid with methanol. It as used as a plant growth regulator and fungicide for grafting of grapevines.


(S)-sertaconazole

A 1-{2-[(7-chloro-1-benzothiophen-3-yl)methoxy]-2-(2,4-dichlorophenyl)ethyl}imidazole that is the (S)-enantiomer of sertaconazole.


(R)-triarimol

A (2,4-dichlorophenyl)(phenyl)pyrimidin-5-ylmethanol that has R configuration.


dichlorophenyl dicarboximide fungicide

A dicarboximide fungicide in which the nitrogen of the dicarboximide group is substituted by a dichlorophenyl group.


The (4S,5R)-stereoisomer of isocycloseram.


fipronil-sulfide

A member of the class of pyrazoles that is 1H-pyrazole that is substituted at positions 1, 3, 4, and 5 by 2,6-dichloro-4-(trifluoromethyl)phenyl, cyano, (trifluoromethyl)sulfanyl, and amino groups, respectively. It is a metabolite of the agrochemical fipronil.


TUBULOZOLE

A carbamate ester that is the ethyl ester of [4-({[2-(2,4-dichlorophenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methyl}sulfanyl)phenyl]carbamic acid.


destosyl pyrazolate

A member of the class of pyrazoles that is pyrazolynate in which the tosylate ester has been hydrolysed to the corresponding hydroxy compound. The active herbicide of the proherbicides pyrazolynate and pyrazoxyfen.


5-hydroxydiclofenac quinone imine

A quinone imine that is a metabolite of diclofenac arising from 5-hydroxylation followed by oxidation.


avilamycin A

An oligosaccharide derivative that is produced by Streptomyces viridochromogenes and exhibits antibiotic properties.


cyclanilide

A monocarboxylic acid that is cyclopropanecarboxylic acid that is substituted by a 3,5-dichlorophenylcarbamoyl group at position 1. It is a plant growth regulator which is used as a cotton harvest aid.


A non-proteinogenic amino acid derivative that is methyl alaninate substituted by a tert-butoxycarbonyl group at the N and a 2-(2,6-dichlorophenyl)-4-(phenylsulfanyl)-1,2,3,4,4a,8a-hexahydro-6-quinolyl group at position 3.


(R)-DICHLORPROP

The R- (active) enantiomer of dichlorprop. It is used as a herbicide for killing annual and broad leaf weeds.


TRIARIMOL

A member of the class of pyrimidines that is methanol in which the hydrogens of the methyl group have been replaced by pyrimidin-5-yl, phenyl, and 2,4-dichlorophenyl groups, respectively.


(R)-leptophos

The (R)-enantiomer of leptophos.


(S)-crizotinib

A 3-[1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-[1-(piperidin-4-yl)pyrazol-4-yl]pyridin-2-amine that is the (S)-enantiomer of crizotinib.


An N(2)-acyl-L-glutamine that is L-glutamine in which one of the hydrogens of the alpha-amino group has been replaced by a 4-(2,4-dichlorophenoxy)butanoyl group.


A benzoxazine that is 2H-1,4-benzoxazin-3(4H)-one substituted by a hydroxy group at position 5 and a 2-{[2-(cyclohexyl{N-[2-(3,4-dichlorophenyl)ethyl]-beta-alanyl}amino)ethyl]amino}ethyl group at position 8. It is a potent and selective inhibitor of SMYD2.


(S)-lorglumide

An N(2)-(3,4-dichlorobenzoyl)-N,N-dipentyl-alpha-glutamine that has (S)-configuration (the racemate is lorglumide, a CCK antagonist).


(S)-diclofop-methyl

A methyl 2-[4-(2,4-dichlorophenoxy)phenoxy]propanoate that is the (S)-enantiomer of diclofop-methyl.


The (4R,5R)-stereoisomer of isocycloseram.


A dichlorohydroquinone that is hydroquinone substituted by chloro groups at positions 2 and 5 respectively.


An  alanine derivative that is alanine substituted by  a methyl and a 2,6-dichlorobenzyl group at N and a 2-(2,6-dichlorophenyl)-6-quinolyl group at position 3.


(S)-diniconazole

A (1E)-1-(2,4-dichlorophenyl)-4,4-dimethyl-2-(1,2,4-triazol-1-yl)pent-1-en-3-ol that is the (S)-enantiomer of diniconazole.


An alpha-amino acid ester that is methyl alaninate substituted by a 2-(2,6-dichlorophenyl)quinolin-6-yl group at position 3.


(R)-mefenpyr

A 1-(2,4-dichlorophenyl)-5-methyl-4,5-dihydro-1H-pyrazole-3,5-dicarboxylic acid that has R configuration.


A  dichlorobenzoyl-CoA having 2,4-dichlorobenzoyl as the S-acyl group.


A pyrazolylpiperidine that consists of 4-(pyrazol-1-yl)piperidine carrying a 2-amino-3-[1-(2,6-dichloro-3-fluorophenyl)ethoxy]pyridin-5-yl group at the 4-position of the pyrazole ring.


A member of the class of cyclobutanes that is cyclobutane substituted by [2-(trifluoromethyl)pyridine-3-carbonyl]amino and 2,4-dichlorophenyl groups at positions 1 and 2, respectively.


A hydroxybiphenyl that is catechol in which the hydrogen at position 3 has been replaced by a 2,6-dichlorophenyl group.


tiorantraniliprole

A secondary carboxamide resulting from the formal condensation of the carboxylic acid group of 3-bromo-1-(3-chloropyridin-2-yl)-1H-pyrazole-5-carboxylic acid with the primary amino group of 2-amino-3,5-dichloro-N-(propan-2-yl)benzenecarbothioamide. It is an insecticide from Zhejiang Udragon Bioscience.


azafenidin

A triazolopyridine that is 5,6,7,8-tetrahydro[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one which is substituted at position 2 by a 2,4-dichloro-5-(prop-2-yn-1-yloxy)phenyl group. A protoporphyrinogen oxidase inhibitor, it is used as a herbicide to control weeds in fruit crops such as pineapple, citrus, melons, and grapes. Not approved for use within the European Union.


A member of the class of  hydroxybiphenyls formed formally by chlorination of biphenyl-4,4'-diol at C-3, -3', -5 and -5'.


An member of the class of hydroxybiphenyls formed formally by chlorination of biphenyl-3-ol at C-2' and -5'.


A dichlorophenol with the chloro substituents at positions 2 and 6.


A member of the class of  hydroxybiphenyls that is biphenyl-4-ol substituted by chloro groups at positions 2', 3, 5 and 5' respectively.


A dichlorocatechol in which the two chloro groups are located at positions 3 and 6.


CHLORONEB

A dimethoxybenzene that is p-dimethoxybenzene which is substituted by chlorines at positions 2 and 5. A fungicide formerly used as a seed treatment, it is not approved for use in the European Union.


A monocarboxylic acid that is the 4'-hydroxylated metabolite of diclofenac.


A naphthalen-1-one having an N-2,4-dichlorophenylglycinamido group at the 2-position and a [(2,4-dichlorophenyl)amino]sulfonyl group at the 7-position.


pyrafluprole

A member of the class of pyrazoles that is 1H-pyrazole which is substituted by a 2,6-dichloro-4-(trifluoromethyl)phenyl, nitrile, (fluoromethyl)sulfanediyl and [(pyrazin-2-yl)methyl]nitrilo groups at positions 1,3,4 and 5, respectively. It is an experimental insecticide introduced by Nihon Nohyaku Co Ltd, Japan.


name: systemic lupus erythematosus, susceptibility to, 14


description: Evidence of type 1 diabetes mellitus with periodontal disease.


name: Stage IV Adrenal Cortex Carcinoma AJCC v8

description: Stage IV includes: Any T, Any N, M1. M1: Distant metastasis. (from AJCC 8th Ed.)


description: A sympathetic paraganglioma arising from the retroperitoneum, outside the adrenal gland.


Childhood Adrenal Cortical Carcinoma

description: A carcinoma that arises from the adrenal cortex and occurs during childhood.


Retroperitoneal Ganglioneuroma

description: A ganglioneuroma arising from the retroperitoneum.


name: Adrenal Cortical Carcinoma by AJCC v7 Stage

description: A term that refers to the staging of adrenal cortical carcinoma, following the rules of the TNM AJCC v7 classification system.


Adrenal Cortical Oncocytic Carcinoma

description: A carcinoma that arises from the adrenal cortex and is composed of oncocytic cells that constitute more than 90% of malignant cells.


name: Stage III Adrenal Cortex Carcinoma AJCC v8

description: Stage III includes: (T1, N1, M0); (T2, N1, M0); (T3, Any N, M0); (T4, Any N, M0). T1: Tumor measuring 5 cm or less in greatest dimension, with no extra-adrenal invasion. T2: Tumor measuring more than 5 cm in greatest dimension, with no extra-adrenal invasion. T3: Tumor of any size with local invasion but not invading adjacent organs. T4: Tumor of any size that invades adjacent organs (kidney, diaphragm, pancreas, spleen, or liver) or large blood vessels (renal vein or vena cava). N1: Metastasis in regional lymph node(s). M0: No distant metastasis. (from AJCC 8th Ed.)


name: Adrenal Cortical Carcinoma by AJCC v8 Stage

description: A term that refers to the staging of adrenal cortical carcinoma, following the rules of the TNM AJCC v8 classification system. Adrenal medullary pheochromocytoma is staged according to the classification for adrenal neuroendocrine tumors. There is no AJCC staging system for neuroblastic tumors of the adrenal gland. (from AJCC 8th Ed.)


Adrenal Cortical Oncocytic Adenoma

description: A usually non-functioning variant of adrenal cortex adenoma, composed of large cells with abundant granular eosinophilic cytoplasm.


name: Glomerulosa Cell Adrenal Cortical Adenoma

description: An adenoma of the adrenal cortex composed of neoplastic cells with cytologic features of glomerulosa cells.


name: Stage III Adrenal Cortex Carcinoma AJCC v7

description: Stage III includes: (T1, N1, M0); (T2, N1, M0); (T3, N0, M0).  T1: Tumor 5 cm or less in greatest dimension, no extra-adrenal invasion.  T2: Tumor greater than 5 cm, no extra-adrenal invasion.  T3: Tumor of any size with local invasion, but not invading adjacent organs.  N1: Metastasis in regional lymph node(s).  N0: No regional lymph node metastasis.  M0: No distant metastasis. (AJCC 7th ed.)


Adrenal Gland Ganglioneuroma

description: A ganglioneuroma arising from the adrenal gland.


Adrenal Gland Lipoma

description: A rare lipoma that arises from the adrenal gland.


name: Recurrent Adrenal Gland Pheochromocytoma

description: The reemergence of pheochromocytoma following surgical removal.


Clear Cell Adrenal Cortical Adenoma

description: An adenoma of the adrenal cortex composed of neoplastic clear cells containing intracytoplasmic lipid droplets.


name: Stage IV Adrenal Cortex Carcinoma AJCC v7

description: Stage IV includes: (T3, N1, M0); (T4, N0, M0); (T4, N1, M0); (Any T, Any N, M1).  T3: Tumor of any size with local invasion, but not invading adjacent organs.  T4: Tumor of any size with invasion of adjacent organs.  N1: Metastasis in regional lymph node(s).  N0: No regional lymph node metastasis.  M0: No distant metastasis. M1: Distant metastasis.  (AJCC 7th ed.)


name: Retroperitoneal Gastrointestinal Stromal Tumor

description: A gastrointestinal stromal tumor that arises from the retroperitoneum. This is an extragastrointestinal tumor, meaning that it does not arise directly from the gastrointestinal tract.


Leiomyoma of the adrenal gland

description: A rare leiomyoma that arises from the adrenal gland.


Benign neoplasm of retroperitoneum

description: A neoplasm that arises from the retroperitoneum and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential.


Benign neoplasm of adrenal cortex

description: A neoplasm that arises from the adrenal cortex and is characterized by the absence of atypical or malignant cytological and architectural features, and absence of invasive features or metastatic potential.


Childhood Adrenal Cortical Adenoma

description: An adenoma of the adrenal cortex that occurs during childhood.


name: Stage I Adrenal Cortex Carcinoma AJCC v7

description: Stage I includes: T1, N0, M0.  T1: Tumor 5 cm or less in greatest dimension, no extra-adrenal invasion. N0: No regional lymph node metastasis.  M0: No distant metastasis.  (AJCC 7th ed.)


name: Hereditary Adrenal Gland Pheochromocytoma

description: A hereditary adrenal gland pheochromocytoma caused by mutations in SDHB, SDHC, and SDHD genes.


Adrenal Cortical Adenomatoid Tumor

description: A benign adrenal cortical neoplasm deriving from mesothelial cells.


name: Locally Advanced Adrenal Gland Pheochromocytoma

description: Adrenal gland pheochromocytoma that has spread from its original site of growth to nearby tissues or lymph nodes.


Adrenal Cortical Myxoid Carcinoma

description: A carcinoma that arises from the adrenal cortex and is characterized by the presence of abundant extracellular connective tissue mucin.


name: Locally Advanced Adrenal Cortical Carcinoma

description: Adrenal cortical carcinoma that has spread from its original site of growth to nearby tissues or lymph nodes.


Adrenal Gland Lymphangioma

description: A rare lymphangioma that arises from the adrenal gland.


name: Stage II Adrenal Cortex Carcinoma AJCC v7

description: Stage II includes: T2, N0, M0.  T2: Tumor greater than 5 cm, no extra-adrenal invasion.  N0: No regional lymph node metastasis.  M0: No distant metastasis. (AJCC 7th ed.)


Adrenal Gland Lymphoma

description: A rare lymphoma that arises from the adrenal gland.


Adrenal Cortical Low Grade Carcinoma

description: A carcinoma that arises from the adrenal cortex and is characterized by the presence of twenty or less mitoses per ten square millimeters.


name: Metastatic Adrenal Gland Composite Pheochromocytoma

description: An adrenal gland composite pheochromocytoma that metastasizes to other anatomic sites.


Metastatic Adrenal Cortical Carcinoma

description: A carcinoma that arises from the adrenal cortex and has metastasized to another anatomic site.


Adrenal Gland Hemangioma

description: A rare hemangioma that arises from the adrenal gland.


name: Superior and Inferior Paraaortic Paraganglioma

description: An extra-adrenal sympathetic paraganglioma arising from paraganglia located along the aorta, including suprarenal, infrarenal, and renal hilar sites.  In functional tumors, the hypersecretion of catecholamines results in hypertension.


name: Metastatic Carcinoma in the Adrenal Cortex

description: A carcinoma that has spread to the adrenal cortex from an adjacent or distal anatomic site.


name: Androgen-Producing Adrenal Cortical Adenoma

description: A rare adenoma of the adrenal cortex that produces androgens.  Female patients usually have symptoms related to virilism.


name: Unresectable Adrenal Gland Pheochromocytoma

description: Adrenal gland pheochromocytoma that is not amenable to surgical resection.


Compact Cell Adrenal Cortical Adenoma

description: An adenoma of the adrenal cortex composed of neoplastic compact cells with eosinophilic cytoplasm.


Adrenal Cortical Sex Cord-Stromal Tumor

description: An extremely rare sex cord-stromal tumor that arises from the adrenal cortex. The reported cases were solitary and unilateral.


name: Adrenal Gland Composite Pheochromocytoma

description: A neoplasm that arises from the adrenal medulla and combines morphologic characteristics of pheochromocytoma and neuroectodermal tumors such as neuroblastoma, ganglioneuroma, ganglioneuroblastoma, or peripheral nerve sheath tumor.


name: Adrenal Gland Ganglioneuroblastoma, Intermixed

description: An intermixed ganglioneuroblastoma arising from the adrenal gland.


Adrenal Cortical High Grade Carcinoma

description: A carcinoma that arises from the adrenal cortex and is characterized by the presence of more than twenty mitoses per ten square millimeters.


name: Stage I Adrenal Cortex Carcinoma AJCC v8

description: Stage I includes: T1, N0, M0. T1: Tumor measuring 5 cm or less in greatest dimension, with no extra-adrenal invasion. N0: No regional lymph node metastasis. M0: No distant metastasis. (from AJCC 8th Ed.)


Advanced Adrenal Gland Pheochromocytoma

description: An adrenal gland pheochromocytoma that has spread extensively to other anatomic sites or is no longer responding to treatment.


Adrenal Cortical Melanoma

description: A rare melanoma that arises within the adrenal cortex.


Adrenal Gland Schwannoma

description: A rare schwannoma that arises from the adrenal medulla.


Mixed Cell Adrenal Cortical Adenoma

description: An adenoma of the adrenal cortex composed of a mixed neoplastic cellular population, including varying numbers of neoplastic clear and compact cells.


name: Stage II Adrenal Cortex Carcinoma AJCC v8

description: Stage II includes: T2, N0, M0. T2: Tumor measuring more than 5 cm in greatest dimension, with no extra-adrenal invasion. N0: No regional lymph node metastasis. M0: No distant metastasis. (from AJCC 8th Ed.)


name: Adrenal Gland Ganglioneuroblastoma, Nodular

description: A nodular ganglioneuroblastoma arising from the adrenal gland.


Unresectable Adrenal Cortical Carcinoma

description: Adrenal cortical carcinoma that is not amenable to surgical resection.


name: Recurrent Malignant Retroperitoneal Neoplasm

description: The reemergence of a malignant retroperitoneal neoplasm after a period of remission.


name: Non-Metastatic Adrenal Gland Composite Pheochromocytoma

description: A composite pheochromocytoma that is confined to the adrenal gland.


Regional Adrenal Gland Pheochromocytoma

description: A pheochromocytoma that has not spread to other regions.


name: Heavily Pigmented Adrenal Cortical Adenoma

description: A usually functioning adenoma of the adrenal cortex. Grossly, it has a dark brown appearance and is characterized by the presence of neoplastic cells containing abundant intracytoplasmic lipofuscin. It may be associated with Cushing syndrome.


Recurrent Adrenal Cortical Carcinoma

description: The reemergence of adrenal cortical carcinoma after a period of remission.


Anaplastic adrenocortical carcinoma

description: A carcinoma that arises from the adrenal cortex and is characterized by the partial or complete loss of adrenal cortical differentiation.


Refractory Adrenal Cortical Carcinoma

description: Adrenal cortical carcinoma that is resistant to treatment.


name: estrogen-producing adrenal cortical adenoma

description: A rare adenoma of the adrenal cortex that produces estrogens.  Male patients may develop gynecomastia and impotence.


name: Metastatic malignant neoplasm to adrenal gland

description: A malignant tumor that has spread to the adrenal gland from an adjacent or distant anatomic site.  The majority of cases are metastatic carcinomas, and less frequently lymphomas.


Grade 1 Conjunctivitis, CTCAE

description: Asymptomatic or mild symptoms; intervention not indicated


name: Merkel Cell Carcinoma of Other Part of Trunk

description: Evidence of Merkel cell carcinoma of other part of trunk.


name: Grade 5 Middle Ear Infection with Normal Absolute Neutrophil Count or Grade 1 or 2 Neutrophils, CTCAE


name: Acute Myeloid Leukemia with Complex Karyotype

description: Acute myeloid leukemia associated with at least 3 unrelated clonal chromosomal abnormalities.


A polyketide obtainbed by allylic hydroxylation of dihydromonacolin L acid at the 3alpha-position.


A pentol that is 12,16-dimethylicosan-2-one in which the five hydroxy substituents are located at positions 3, 5, 10, 14 and 15.


name: Thyroid Cancer pT4b Anaplastic Carcinoma TNM Finding v7

description: Anaplastic carcinoma with gross extrathyroid extension. (from AJCC 7th Ed.)


description: Evidence of cocaine abuse with cocaine-induced psychotic disorder with delusions.


Forceps Injury

description: Birth injury sustained during a forceps-assisted delivery.


A steroid glucosiduronic acid that is 2-hydroxyestrone having a single beta-D-glucuronic acid residue attached at position 3.


Grade 5 Pericardial Tamponade, CTCAE

description: Death


name: Grade 1 Upper Extremity Vein Injury, CTCAE


name: Grade 4 Upper Extremity Vein Injury, CTCAE


name: Grade 2 Upper Extremity Vein Injury, CTCAE


name: Grade 5 Upper Extremity Vein Injury, CTCAE


name: Childhood Neuroblastoma by Toronto Guidelines v2 Stage

description: A term that refers to the staging of childhood neuroblastoma according to the Toronto childhood cancer staging guidelines v2.


name: Familial Adenomatous Polyposis Associated Medulloblastoma

description: A medulloblastoma developing in patients with familiar adenomatous polyposis syndrome.  It is observed in patients with Turcot syndrome, type 2.


Medulloblastoma, SHH-4

description: Medulloblastoma, SHH-activated, characterized by mutations of U1-snRNA and TERT genes. Mutations of PTCH1 or SMO genes are usually also present. It affects mostly adults.


Sellar Neuroblastoma

description: A rare neuroblastoma arising from the sella turcica.


Refractory Ganglioneuroblastoma

description: Ganglioneuroblastoma that does not respond to treatment.


name: Embryonal Tumor with Multilayered Rosettes, DICER1-Mutated

description: An embryonal tumor with multilayered rosettes characterized by the presence of DICER1 mutation. Approximately half of embryonal tumors with multilayered rosettes that lack a C19MC alteration carry DICER1 mutations.


Refractory Dedifferentiated Chordoma

description: A dedifferentiated chordoma that does not respond to treatment.


Childhood Brain Neuroblastoma

description: A neuroblastoma that arises from the brain during childhood.


Refractory Rhabdoid Tumor

description: Rhabdoid tumor that does not respond to treatment.


name: Stage M1 Childhood Central Nervous System Embryonal Tumor by Toronto Guidelines v2

description: Tumor cells in the CSF. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)


Hereditary Neuroblastoma

description: Genetic inheritance of neuroblastoma caused by mutations in the ALK or PHOX2B genes.  Familial neuroblastomas have a higher incidence of multiple primary tumors and are diagnosed at an earlier age.


name: Childhood Central Nervous System Ganglioneuroblastoma

description: A central nervous system ganglioneuroblastoma that occurs during childhood.


name: Stage L1 Childhood Neuroblastoma by Toronto Guidelines v2

description: Localized tumor that does not involve any vital structures as defined by the list of IDRFs (i.e., there are no IDRFs) and the tumor must be confined within one body compartment, neck, chest, abdomen, or pelvis. An intraspinal tumor extension that does not fulfill the criteria for an IDRF is consistent with stage L1. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)


Advanced Chordoma

description: A chordoma that has spread extensively to other anatomic sites or is no longer responding to treatment.


name: Central Nervous System Embryonal Tumor, Not Otherwise Specified with Leptomeningeal Spread

description: A central nervous system embryonal tumor, not otherwise specified which has spread from its original site to the leptomeninges surrounding the brain and spinal cord.


Visual Pathway Medulloepithelioma

description: A very rare, benign or malignant embryonal neoplasm affecting the visual pathway during childhood. It arises from primitive medullary epithelium.


name: Embryonal Tumor with Multilayered Rosettes of the Fourth Ventricle

description: An embryonal tumor with multilayered rosettes that arises from the fourth ventricle.


Stage M4 Medulloblastoma

description: Metastasis outside the cerebrospinal axis. (Chang CH, Housepian EM, Herbert C. Radiology, 1969; 93(6):1351-9.)


name: Stage M3 Childhood Medulloblastoma by Toronto Guidelines v2

description: Visible metastasis in spine or visible metastasis in cervicomedullary junction. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)


Atypical Teratoid/Rhabdoid Tumor-TYR

description: Atypical teratoid/rhabdoid tumor characterized by overexpression of melanosomal genes (TYR, TYRP, MITF, and OTX2).


name: Stage M3 Childhood Central Nervous System Embryonal Tumor by Toronto Guidelines v2


name: Neuroblastoma of the Adrenal Gland and Sympathetic Nervous System

description: A common pediatric extracranial tumor arising from neural crest cells.  It involves the adrenal medulla and the sympathetic nervous system.


name: Adult Supratentorial Embryonal Tumor, Not Otherwise Specified

description: A supratentorial embryonal tumor, not otherwise specified that occurs in adults.


Anaplastic Medulloblastoma

description: A medulloblastoma characterized by marked nuclear pleomorphism, and high mitotic activity.


Paratesticular Wilms Tumor

description: A rare Wilms tumor that arises from the paratesticular structures.


name: Childhood Neuroblastoma by Toronto Guidelines v2 Stage, Tier 2

description: A term that refers to the staging of childhood neuroblastoma according to the tier 2 Toronto childhood cancer staging guidelines v2.


Atypical Teratoid/Rhabdoid Tumor-SHH

description: Atypical teratoid/rhabdoid tumor characterized by overexpression of genes in the sonic hedgehog (SHH) pathway (GLI2, BOC, PTCHD2, and MYCN).


Prostate Wilms Tumor

description: A rare Wilms tumor affecting the prostate gland.


name: Childhood Atypical Teratoid/Rhabdoid Tumor

description: An atypical teratoid/rhabdoid tumor occurring in children.


name: Stage M0 Childhood Medulloblastoma by Toronto Guidelines v2

description: No visible disease on imaging (MRI brain and spine) beyond primary site of disease and no tumor cells in the CSF. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)


name: Localized Childhood Neuroblastoma by Toronto Guidelines v2

description: Localized tumor not involving vital structures and confined to one body compartment. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)


description: An intermixed ganglioneuroblastoma that occurs during childhood.


name: Pineoblastoma miRNA Processing Altered 1

description: Pineoblastoma characterized by alterations in genes involved in miRNA biogenesis (DICER1, DROSHA, and DGCR8). It may manifest as a sporadic tumor or part of DICER1 syndrome. It affects children.


Localized Resectable Neuroblastoma

description: Neuroblastoma that is confined to a specific site and is amenable to surgical removal.


name: Refractory Peripheral Primitive Neuroectodermal Tumor

description: Peripheral primitive neuroectodermal tumor that does not respond to treatment.


Recurrent Rhabdoid Tumor

description: The reemergence of rhabdoid tumor after a period of remission.


Thyroblastoma

description: A high-grade, rapidly growing malignant embryonal neoplasm that arises from the thyroid gland. It is characterized by the presence of primitive follicular-like structures surrounded by primitive small cells and primitive spindle cell mesenchymal stroma. It is associated with DICER1 gene mutations. The prognosis is poor.


Extra-osseous Ewing's sarcoma recurrent

description: Reemergence of extraskeletal Ewing sarcoma after a period of remission.


name: Peripheral neuroepithelioma of bone metastatic

description: A small round cell tumor of the bone with neural differentiation that has spread from its original site of growth to another anatomic site.


Unresectable Ewing Sarcoma

description: A Ewing sarcoma which is not amenable to surgical resection.


name: Stage M4 Embryonal Tumor with Multilayered Rosettes

description: Metastasis outside the cerebrospinal axis. (Chang CH, Housepian EM, Herbert C. Radiology, 1969; 93(6):1351-9.)


name: Central Nervous System Embryonal Neoplasm

description: A malignant neoplasm of embryonal origin, arising from the central nervous system.  It usually affects children.  Representative examples include ependymoblastoma, medulloblastoma, and atypical teratoid/rhabdoid tumor.


Locally Advanced Ewing Sarcoma

description: Ewing sarcoma that has spread from its original site of growth to nearby tissues or lymph nodes.


name: Locally Advanced Olfactory Neuroblastoma

description: Olfactory neuroblastoma that has spread from its original site of growth to nearby tissues or lymph nodes.


name: Childhood Medulloblastoma by Toronto Guidelines v2 Stage, Tier 1

description: A term that refers to the staging of childhood medulloblastoma according to the tier 1 Toronto childhood cancer staging guidelines v2.


Stage M1 Pineoblastoma

description: Microscopic tumor cells are detected in the cerebrospinal fluid. (Chang CH, Housepian EM, Herbert C. Radiology, 1969; 93(6):1351-9.)


Sellar Dedifferentiated Chordoma

description: A dedifferentiated chordoma that arises from the sellar region.


name: Stage M2 Atypical Teratoid/Rhabdoid Tumor

description: Gross nodular seeding is detected in the cerebellar/cerebral subarachnoid space or in the third or lateral ventricles. (Chang CH, Housepian EM, Herbert C. Radiology, 1969; 93(6):1351-9.)


name: Stage M0 Atypical Teratoid/Rhabdoid Tumor

description: No evidence of subarachnoid or hematogenous metastasis. (Chang CH, Housepian EM, Herbert C. Radiology, 1969; 93(6):1351-9.)


name: Recurrent Childhood Central Nervous System Embryonal Neoplasm

description: The reemergence of childhood central nervous system embryonal neoplasm after a period of remission.


Resectable Neuroblastoma

description: Neuroblastoma that is amenable to surgical resection.


Childhood Brain Ganglioneuroblastoma

description: A ganglioneuroblastoma that arises from the brain and occurs during childhood.


name: Stage L2 Childhood Neuroblastoma by Toronto Guidelines v2

description: Locoregional tumor with one or more IDRFs. The tumor may be ipsilateral contiguous within body compartments (i.e., a left-sided abdominal tumor with left-sided lung, bone or pleura involvement should be considered stage L2). However, a clearly left-sided abdominal tumor with right-sided lung, bone or pleura (or vice-versa) involvement is defined as metastatic disease. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)


name: Childhood Neuroblastoma by Toronto Guidelines v2 Stage, Tier 1

description: A term that refers to the staging of childhood neuroblastoma according to the tier 1 Toronto childhood cancer staging guidelines v2.


High Risk Neuroblastoma

description: Neuroblastoma usually presenting with metastatic disease and MYCN gene amplifications.


name: embryonal tumor with multilayered rosettes

description: A central nervous system embryonal tumor characterized by the presence of multilayered rosette formation and typically the presence of amplification of the C19MC region on chromosome 19 (19q13.42) or rarely a DICER1 mutation.


name: Peripheral neuroepithelioma of bone recurrent

description: The reemergence of peripheral primitive neuroectodermal tumor of the bone after a period of remission.


Cribriform Neuroepithelial Tumor

description: A very rare, nonrhabdoid, intraventricular tumor with relatively favorable prognosis.  It is characterized by the presence of neuroepithelial cells forming cribriform patterns, trabeculae, epithelial membrane antigen immunopositivity on epithelial surfaces, and loss of nuclear INI 1 expression.


Sellar Chordoma

description: A chordoma that arises from the sellar region.


description: The reemergence of medulloblastoma, WNT-activated after a period of remission.


Stage 3 Neuroblastoma

description: Unresectable unilateral tumor infiltrating across the midline, with or without regional lymph node involvement; or localized unilateral tumor with contralateral regional lymph node involvement; or midline tumor with bilateral extension by infiltration (unresectable) or by lymph node involvement. The midline is defined as the vertebral column. Tumors originating on one side and crossing the midline must infiltrate to or beyond the opposite side of the vertebral column. (cancer.gov)


name: Refractory Atypical Teratoid/Rhabdoid Tumor

description: An atypical teratoid/rhabdoid tumor that does not respond to treatment.


Stage 4S neuroblastoma

description: Localized primary tumor, as defined for stage 1, 2A, or 2B, with dissemination limited to skin, liver, and/or bone marrow (limited to infants younger than 1 year). Marrow involvement should be minimal (i.e., <10% of total nucleated cells identified as malignant by bone biopsy or by bone marrow aspirate). More extensive bone marrow involvement would be considered stage 4 disease. The results of the MIBG scan, if performed, should be negative for disease in the bone marrow. (cancer.gov)


name: Metastatic Childhood Neuroblastoma by Toronto Guidelines v2

description: Distant metastatic disease (except stage MS). (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)


name: Childhood Central Nervous System Embryonal Tumor by Toronto Guidelines v2 Stage, Tier 2

description: A term that refers to the staging of childhood central nervous system embryonal tumor according to the tier 2 Toronto childhood cancer staging guidelines v2.


name: Localized Childhood Medulloblastoma by Toronto Guidelines v2

description: Localized disease. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)


name: Medulloblastoma with Leptomeningeal Spread

description: A medulloblastoma which has spread from its original site to the leptomeninges surrounding the brain and spinal cord.


Unresectable Rhabdoid Tumor

description: A rhabdoid tumor that is not amenable to surgical resection.


Stage IV Kidney Wilms Tumor

description: Wilms tumor that has spread to other more distant organs, such as the lungs, liver, bones, and brain, or to lymph nodes outside the abdomen (National Wilms Tumor Study Group Staging System)


Poorly Differentiated Neuroblastoma

description: A neuroblastoma in which the differentiating neuroblasts constitute less than five-percent of the tumor cells.


Childhood Ewing Sarcoma

description: A Ewing sarcoma that occurs during childhood.


Skin Ewing Sarcoma

description: A rare Ewing sarcoma that arises from the skin.


name: Recurrent Atypical Teratoid/Rhabdoid Tumor

description: The reemergence of an atypical teratoid/rhabdoid tumor after a period of remission.


name: Stage M0 Childhood Central Nervous System Embryonal Tumor by Toronto Guidelines v2

description: No visible disease on imaging (MRI brain and spine) beyond primary site of disease and no tumor cells in the CSF. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)


name: Atypical Teratoid/Rhabdoid Tumor Molecular Subtypes

description: A term that refers to the classification of atypical teratoid/rhabdoid tumors according to their molecular characteristics.


Unresectable Chordoma

description: A chordoma which is not amenable to surgical resection.


Pineoblastoma, MYC/FOXR2-Activated

description: Pineoblastoma characterized by MYC activation, chromosome 16 losses, and overexpression of FOXR2. It affects young children and is associated with a dismal prognosis.


Locally Advanced Neuroblastoma

description: A neuroblastoma that has spread from its original site of growth to nearby tissues or lymph nodes.


Undifferentiated Neuroblastoma

description: A neuroblastoma characterized by the absence of differentiating neuroblasts.


name: Childhood Medulloblastoma by Toronto Guidelines v2 Stage, Tier 2

description: A term that refers to the staging of childhood medulloblastoma according to the tier 2 Toronto childhood cancer staging guidelines v2.


Stage 2 Neuroblastoma

description: Stage 2 includes stage 2A and stage 2B.  Stage 2A: Localized tumor with incomplete gross excision; representative ipsilateral nonadherent lymph nodes negative for tumor microscopically. Stage 2B: Localized tumor with or without complete gross excision, with ipsilateral nonadherent lymph nodes positive for tumor. Enlarged contralateral lymph nodes must be negative microscopically. (cancer.gov)


Locally Advanced Chordoma

description: A chordoma that has spread from its original site of growth to nearby tissues.


Regional Neuroblastoma

description: A neuroblastoma confined to a specific anatomic region without evidence of dissemination.


Stage M2 Medulloblastoma

description: Gross nodular seeding is detected in the cerebellar/cerebral subarachnoid space or in the third or lateral ventricles. (Chang CH, Housepian EM, Herbert C. Radiology, 1969; 93(6):1351-9.)


name: Ciliary Body Teratoid Medulloepithelioma

description: A rare, unilateral, benign or malignant embryonal neoplasm typically presenting as a ciliary body mass during childhood. It arises from primitive medullary epithelium and contains heterologous elements, particularly cartilage, skeletal muscle, and brain tissue.


Metastatic Olfactory Neuroblastoma

description: Olfactory neuroblastoma that has spread from its original site of growth to other anatomic sites.


name: Pineoblastoma miRNA Processing Altered 2

description: Pineoblastoma characterized by alterations in genes involved in miRNA biogenesis (DICER1, DROSHA, and DGCR8). It may manifest as a sporadic tumor or part of DICER1 syndrome. It affects older children and follows a more favorable course.


name: Extrarenal Rhabdoid Tumor of the Prostate

description: A rare extrarenal rhabdoid tumor affecting the prostate gland.


name: Stage M4 Childhood Central Nervous System Embryonal Tumor by Toronto Guidelines v2

description: Metastasis outside of the central nervous system. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)


name: Refractory Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor

description: A malignant small round cell tumor with or without neural differentiation that is resistant to treatment.


Neuroblastoma recurrent

description: The reemergence of neuroblastoma after a period of remission.


Unresectable Neuroblastoma

description: Neuroblastoma which is not amenable to surgical resection.


Stage 2A Neuroblastoma

description: Localized tumor with incomplete gross excision; representative ipsilateral nonadherent lymph nodes negative for tumor microscopically. (cancer.gov)


name: Sinonasal Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor

description: A Ewing sarcoma that arises from the nasal cavity and paranasal sinuses.


Medulloblastoma Molecular Subtypes

description: A term that refers to the classification of medulloblastomas according to their molecular characteristics.


Metastatic Neuroblastoma

description: A neuroblastoma that has metastasized from its original site of growth to another anatomic site.


Recurrent Childhood Medulloblastoma

description: The reemergence of childhood medulloblastoma after a period of remission.


name: Localized Childhood Central Nervous System Embryonal Tumor by Toronto Guidelines v2

description: Localized disease. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)


name: Childhood Supratentorial Embryonal Tumor, Not Otherwise Specified

description: A supratentorial embryonal tumor, not otherwise specified that occurs in childhood.


name: Extra-osseous Ewing's sarcoma non-metastatic

description: Ewing sarcoma that arises from the soft tissue and is confined to a specific site without evidence of spread to other anatomic sites.


name: Medulloblastoma, Not Otherwise Specified

description: A medulloblastoma which has not been further characterized.


name: MS Childhood Neuroblastoma by Toronto Guidelines v2

description: Metastatic disease confined to skin, liver, and/or bone marrow in a patient less than 18 months (547 days). (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)


name: Stage MS Childhood Neuroblastoma by Toronto Guidelines v2

description: Metastatic disease confined to skin, liver, and/or bone marrow, in a patient less than 18 months (547 days). MIBG scintigraphy must be negative in bone and bone marrow. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)


name: Benign medulloepithelioma of ciliary body

description: A rare, unilateral, benign embryonal neoplasm typically presenting as a ciliary body mass during childhood. It arises from primitive medullary epithelium.


Recurrent tumors of the Ewing's family

description: The reemergence of a malignant small round cell tumor with or without neural differentiation after a period of remission.


name: Malignant medulloepithelioma of ciliary body

description: A rare, unilateral, malignant embryonal neoplasm typically presenting as a ciliary body mass during childhood. It arises from primitive medullary epithelium.


name: Recurrent Primitive Neuroectodermal Tumor

description: The reemergence of a primitive neuroectodermal tumor of the central or the peripheral nervous system after a period of remission.


Anaplastic Kidney Wilms Tumor

description: Wilms tumor of the kidney characterized by the presence of nuclear anaplasia.  Anaplasia is defined by the presence of all of the following: multipolar polyploid mitotic figures, marked nuclear enlargement, and hyperchromasia.  When anaplasia is diffuse, it is associated with an unfavorable clinical outcome.


Disseminated neuroblastoma

description: Any primary tumor with dissemination to distant lymph nodes, bone, bone marrow, liver, skin, and/or other organs, except as defined for stage 4S. (cancer.gov)


Stage II Kidney Wilms Tumor

description: Wilms tumor that is found in the kidney and in the fat, soft tissue, or blood vessels near the kidney. It may have spread to the renal sinus. The renal sinus is the part of the kidney where blood and fluid enter and exit the organ. The tumor can be completely removed with surgery. (National Wilms Tumor Study Group Staging System)


Localized Askin Tumor

description: A small round cell tumor confined to a specific area of the thoracic cavity without evidence of spread to other anatomic sites.


Recurrent Medulloblastoma

description: The reemergence of medulloblastoma after a period of remission.


Recurrent Kidney Wilms Tumor

description: The reemergence of Wilms tumor of the kidney after a period of remission.


name: Stage M4 Atypical Teratoid/Rhabdoid Tumor

description: Metastasis outside the cerebrospinal axis. (Chang CH, Housepian EM, Herbert C. Radiology, 1969; 93(6):1351-9.)


Stage III Kidney Wilms Tumor

description: Wilms tumor that is found in areas near the kidney and cannot be completely removed with surgery. The tumor may have spread to nearby organs and blood vessels or throughout the abdomen and to nearby lymph nodes. Lymph nodes are tiny, bean-shaped organs that help fight infection. Stage III cancer has not spread outside the abdomen. (National Wilms Tumor Study Group Staging System)


name: Central Nervous System Embryonal Tumor with Rhabdoid Features

description: A central nervous system embryonal neoplasm characterized by the presence of histological features consistent with atypical teratoid/rhabdoid tumor and absence of mutations of the INI1 gene or SMARCA4 (BRG1) gene.


name: Central Nervous System Embryonal Tumor, Not Elsewhere Classified

description: A central nervous system embryonal tumor lacking molecular abnormalities that would classify it as one of the molecularly defined central nervous system embryonal neoplasms.


Stage M0 Medulloblastoma

description: No evidence of subarachnoid or hematogenous metastasis. (Chang CH, Housepian EM, Herbert C. Radiology, 1969; 93(6):1351-9.)


Atypical Teratoid/Rhabdoid Tumor-MYC

description: Atypical teratoid/rhabdoid tumor characterized by overexpression of MYC gene.


Refractory Wilms Tumor

description: Wilms tumor that is resistant to treatment.


name: Metastatic Childhood Central Nervous System Embryonal Tumor by Toronto Guidelines v2

description: Disease beyond local site (e.g., other lesions in brain or spine or tumor cells in CSF or distant metastases). (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)


Childhood Ganglioneuroblastoma, Nodular

description: A nodular ganglioneuroblastoma that occurs during childhood.


Unresectable Extrarenal Rhabdoid Tumor

description: Extrarenal rhabdoid tumor that is not amenable to surgical resection.


Stage M3 Medulloblastoma

description: Gross nodular seeding is detected in the spinal subarachnoid space. (Chang CH, Housepian EM, Herbert C. Radiology, 1969; 93(6):1351-9.)


Kadish Stage B Olfactory Neuroblastoma

description: An olfactory neuroblastoma that involves the nasal cavity and paranasal sinuses.


Fourth Ventricle Medulloblastoma

description: A medulloblastoma occurring in the fourth ventricle.


Localized Unresectable Neuroblastoma

description: Neuroblastoma that is confined to a specific site and is not amenable to surgical removal.


name: Stage M1 Childhood Medulloblastoma by Toronto Guidelines v2

description: Tumor cells in the CSF. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)


Pineoblastoma Molecular Subtypes

description: A term that refers to the classification of pineoblastomas according to their molecular characteristics.


Kidney Ewing Sarcoma

description: A rare Ewing sarcoma arising from the kidney.


Kadish Stage A Olfactory Neuroblastoma

description: An olfactory neuroblastoma that is confined to the nasal cavity


name: Stage M3 Embryonal Tumor with Multilayered Rosettes


name: Metastatic Childhood Medulloblastoma by Toronto Guidelines v2


Benign Notochordal Cell Tumor

description: An intraosseous benign tumor of notochord origin that arises in the bones of the base of the skull, vertebral bodies, sacrum or coccyx.  It contains vacuolated tumor cells without atypia, but lacks myxoid matrix, necrosis, and lobular architecture, which are features that characterize its malignant counterpart, chordoma.  Most lesions are incidental findings.


Recurrent Extrarenal Rhabdoid Tumor

description: The reemergence of extrarenal rhabdoid tumor after a period of remission.


name: Central Nervous System Neuroblastoma, FOXR2-Activated

description: A rare central nervous system neoplasm with neuroblastic and/or neuronal differentiation. It is characterized by the presence of structural rearrangements of FOXR2 gene that result in the activation of the transcription factor FOXR2.


name: Refractory Primitive Neuroectodermal Tumor

description: Primitive neuroectodermal tumor that does not respond to treatment.


Metastatic Medulloblastoma

description: Medulloblastoma that has spread from its original site of growth to another anatomic site.


Stage 1 Neuroblastoma

description: Localized tumor with complete gross excision, with or without microscopic residual disease; representative ipsilateral lymph nodes negative for tumor microscopically. (cancer.gov)


Vulvar Ewing Sarcoma

description: Ewing sarcoma arising from the vulva.


Central Nervous System Ewing Sarcoma

description: Ewing sarcoma that arises in the central nervous system.


name: Region 17p13 Allelic Loss Associated Medulloblastoma

description: A medulloblastoma characterized by the loss of one of the p13 regions of chromosome 17.  Loss of genetic material of chromosome arm 17p is the most common molecular genetic abnormality found in medulloblastomas.


Stage M0 Pineoblastoma

description: No evidence of subarachnoid or hematogenous metastasis. (Chang CH, Housepian EM, Herbert C. Radiology, 1969; 93(6):1351-9.)


Recurrent Bone Ewing Sarcoma

description: The reemergence of Ewing sarcoma of the bone after a period of remission.


Stage M2 Pineoblastoma

description: Gross nodular seeding is detected in the cerebellar/cerebral subarachnoid space or in the third or lateral ventricles. (Chang CH, Housepian EM, Herbert C. Radiology, 1969; 93(6):1351-9.)


name: Stage M2 Childhood Central Nervous System Embryonal Tumor by Toronto Guidelines v2

description: Visible metastasis in brain. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)


name: Extra-osseous Ewing's sarcoma metastatic

description: An Ewing sarcoma of the soft tissues which has spread from its original site of growth to another anatomic site.


Sinonasal Olfactory Neuroblastoma

description: An olfactory neuroblastoma that arises from the sinonasal tract.


Childhood Chordoma

description: A rare chordoma that occurs during childhood.


Childhood Kidney Ewing Sarcoma

description: An extremely rare Ewing sarcoma that arises from the kidney during childhood.


Childhood Pineoblastoma

description: A pineoblastoma that occurs during childhood.


Metastatic Chordoma

description: A chordoma that has spread from its original site of growth to other anatomic sites.


name: Stage M Childhood Neuroblastoma by Toronto Guidelines v2

description: Distant metastatic disease (i.e., not contiguous with the primary tumor) except as defined for stage MS. Nonregional (distant) lymph node involvement is metastatic disease. However, an upper abdominal tumor with enlarged lower mediastinal nodes or a pelvic tumor with inguinal lymph node involvement is considered locoregional disease. Ascites and/or a pleural effusion, even with malignant cells, do not constitute metastatic disease unless they are remote from the body compartment of the primary tumor. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)


Medulloblastoma, SHH-1

description: Medulloblastoma, SHH-activated, characterized by SUFU gene mutations and chromosome 2 gain. It affects mostly infants.


Stage I Kidney Wilms Tumor

description: Wilms tumor that is found in one kidney and can be completely removed with surgery. (National Wilms Tumor Study Group Staging System)


Dedifferentiated chordoma

description: A high-grade malignant bone tumor arising from the remnants of the notochord. It is characterized by a lobulated growth pattern, myxoid stroma formation, the presence of physaliphorous cells, and a sarcomatous component.


Recurrent Ganglioneuroblastoma

description: The reemergence of ganglioneuroblastoma after a period of remission.


description: The reemergence of SHH-activated medulloblastoma after a period of remission.


name: Childhood Central Nervous System Embryonal Neoplasm

description: A central nervous system embryonal tumor that occurs during childhood.


name: Peripheral Primitive Neuroectodermal Tumor of the Kidney

description: A small round cell tumor with neural differentiation arising from the kidney.


Recurrent Olfactory Neuroblastoma

description: The reemergence of olfactory neuroblastoma after a period of remission.


Head and Neck Ewing Sarcoma

description: A Ewing sarcoma that arises from the head and neck region. The most frequent sites of involvement are the skull and facial bones, head and neck soft tissue, and mandible.


Childhood Ganglioneuroblastoma

description: A ganglioneuroblastoma that occurs during childhood.


Large cell Ewing sarcoma of bone

description: Ewing sarcoma characterized by the presence of large malignant cells with prominent nucleoli and irregular contours.


Medulloblastoma, SHH-3

description: Medulloblastoma, SHH-activated, characterized by mutations of TP53 and ELP1 genes. It affects older individuals.


name: Childhood Central Nervous System Embryonal Tumor by Toronto Guidelines v2 Stage, Tier 1

description: A term that refers to the staging of childhood central nervous system embryonal tumor according to the tier 1 Toronto childhood cancer staging guidelines v2.


name: Recurrent Childhood Supratentorial Embryonal Tumor, Not Otherwise Specified

description: The reemergence of supratentorial embryonal tumor, not otherwise specified in childhood after a period of remission.


Stage M4 Pineoblastoma

description: Metastasis outside the cerebrospinal axis. (Chang CH, Housepian EM, Herbert C. Radiology, 1969; 93(6):1351-9.)


PNET of bone localised

description: A small round cell tumor with neural differentiation that is confined to a specific area of the bone and has not spread to other anatomic sites.


name: Embryonal Tumor with Multilayered Rosettes without C19MC Alteration

description: An embryonal tumor with multilayered rosettes characterized by the absence of C19MC amplification. Approximately half of embryonal tumors with multilayered rosettes that lack a C19MC alteration carry DICER1 mutations.


Kadish Stage C Olfactory Neuroblastoma

description: An olfactory neuroblastoma that extends beyond the nasal cavity and paranasal sinuses.


name: Nevoid Basal Cell Carcinoma Syndrome Associated Medulloblastoma

description: A medulloblastoma developing in patients with multiple basal cell carcinomas.  It is observed in patients with nevoid basal cell carcinoma syndrome and it is associated with PTCH gene inactivation.


description: Medulloblastoma, WNT-activated that is resistant to treatment.


Refractory Medulloblastoma

description: Medulloblastoma that does not respond to treatment.


name: Stage M2 Childhood Medulloblastoma by Toronto Guidelines v2

description: Visible metastasis in brain. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)


name: Stage M0 Embryonal Tumor with Multilayered Rosettes

description: No evidence of subarachnoid or hematogenous metastasis. (Chang CH, Housepian EM, Herbert C. Radiology, 1969; 93(6):1351-9.)


name: Stage M4 Childhood Medulloblastoma by Toronto Guidelines v2

description: Metastasis outside of the central nervous system. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)


Stage 2B Neuroblastoma

description: Localized tumor with or without complete gross excision, with ipsilateral nonadherent lymph nodes positive for tumor. Enlarged contralateral lymph nodes must be negative microscopically. (cancer.gov)


name: Childhood Central Nervous System Neuroblastoma

description: A neuroblastoma that arises from the central nervous system and occurs during childhood.


description: SHH-activated medulloblastoma that does not respond to treatment.


Metastatic Bone Ewing Sarcoma

description: An Ewing sarcoma of the bone which has spread from its original site of growth to another anatomic site.


name: Metastatic Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor

description: A small round cell tumor with or without neural differentiation that has spread from its original site of growth to another anatomic site.


Stage M1 Medulloblastoma

description: Microscopic tumor cells are detected in the cerebrospinal fluid. (Chang CH, Housepian EM, Herbert C. Radiology, 1969; 93(6):1351-9.)


Metastatic Ewing's Sarcoma

description: Ewing sarcoma that has spread from its original site of growth to another anatomic site.


Refractory Ewing Sarcoma

description: Ewing sarcoma that does not respond to treatment.


name: Recurrent Peripheral Primitive Neuroectodermal Tumor

description: The reemergence of a small round cell tumor with neural differentiation after a period of remission.


ELP1-Associated Medulloblastoma

description: An SHH-activated, TP53-wildtype medulloblastoma caused by germline ELP1 gene variations and develops during childhood.


name: Stage M1 Atypical Teratoid/Rhabdoid Tumor


name: Locoregional Childhood Neuroblastoma by Toronto Guidelines v2

description: Locoregional tumor with spread. (Childhood cancer staging for population registries according to the Toronto Childhood Cancer Stage Guidelines - Version 2. Cancer Council Queensland and Cancer Australia: Brisbane, Australia; 2021.)


Mesoblastic nephroma, mixed

description: A congenital mesoblastic nephroma characterized by the presence of classic and cellular areas.


Refractory Chordoma

description: A chordoma that does not respond to treatment.


name: Childhood Central Nervous System Embryonal Tumor by Toronto Guidelines v2 Stage

description: A term that refers to the staging of childhood central nervous system embryonal tumor according to the Toronto childhood cancer staging guidelines v2.


name: Central Nervous System Ganglioneuroblastoma

description: A malignant central nervous system neoplasm characterized by the presence of poorly differentiated or undifferentiated neuroepithelial cells and ganglion cells.


Childhood Neuroblastoma

description: A neuroblastoma that occurs during childhood.


Ewing's sarcoma recurrent

description: Ewing sarcoma which has recurred after treatment and/or remission. While initial complete responses are not uncommon, there is a fair chance of relapse as late as one to two decades after initial therapy.


name: Stage M2 Embryonal Tumor with Multilayered Rosettes

description: Gross nodular seeding is detected in the cerebellar/cerebral subarachnoid space or in the third or lateral ventricles. (Chang CH, Housepian EM, Herbert C. Radiology, 1969; 93(6):1351-9.)


name: Stage M3 Atypical Teratoid/Rhabdoid Tumor

description: Gross nodular seeding is detected in the spinal subarachnoid space. (Chang CH, Housepian EM, Herbert C. Radiology, 1969; 93(6):1351-9.)


name: Childhood Medulloblastoma by Toronto Guidelines v2 Stage

description: A term that refers to the staging of childhood medulloblastoma according to the Toronto childhood cancer staging guidelines v2.


Pineoblastoma, RB1-Altered

description: Pineoblastoma characterized by alterations in RB1 gene. It may develop in the setting of congenital retinoblastoma, also known as trilateral retinoblastoma. It affects young children and is associated with a dismal prognosis.


ethyl dihydrogen phosphate

A monoalkyl phosphate epitope having ethyl as the alkyl group.


A 3beta-sterol having double bonds in the 5- and 7-positions and a methylene group at position 24.


(S)-fenarimol

A (2-chlorophenyl)(4-chlorophenyl)pyrimidin-5-ylmethanol that has S configuration.


Hemoglobin Alpha Normal Genotype

description: A genetic finding indicating that both copies of chromosome 16 each has two functional copies of the hemoglobin alpha (HBA) genes, which includes 2 maternal alpha genes and 2 paternal alpha genes. This genotype is characterized by normal alpha globin production.


Acute cholecystitis without calculus

description: Acute inflammation of the gallbladder in the absence of gallstones


name: Calculus of gallbladder with cholecystitis

description: An acute or chronic inflammation of the gallbladder associated with the presence of gallstones.


Chronic acalculous cholecystitis

description: Chronic cholecystitis not associated with the presence of gallstones.


name: 5-nitro-2-furancarboxylic acid (5-phenyl-1,3,4-oxadiazol-2-yl)methyl ester


name: Grade 4 Cervix Infection with Unknown Absolute Neutrophil Count, CTCAE


name: Intracranial Mesenchymal Tumor, FET-CREB Fusion-Positive

description: A provisional entity that refers to a group of neoplasms with a broad morphological spectrum, characterized by fusion of a FET family gene (usually EWSR1 and rarely FUS) with a member of the CREB family of transcription factors (CREB1, ATF1, or CREM). It includes entities previously termed intracranial angiomatoid fibrous histiocytoma or intracranial myxoid mesenchymal tumor. It is usually located in the supratentorial brain and mostly affects children and young adults. There is a spectrum of clinical behaviors ranging from slowly growing tumors to rapid recurrences, and rarely metastases.


A glycotriaosylceramide having alpha-D-galactosyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosyl as the glycotriaosyl component attached to the Cer(d18:1/20:0).


name: Untreated Childhood Visual Pathway Glioma

description: A finding of visual pathway glioma in childhood that has not been treated.


(3R,11R)-3,11-dihydroxylauric acid

An (omega-1)-hydroxy fatty acid that is (11R)-11-hydroxylauric acid in which the 3-pro-R hydrogen is replaced by a hydroxy group.


capsaicinoid

A family of aromatic fatty amides produced as secondary metabolites by chilli peppers.


A capsaicinoid that is a dimer obtained by replacement of the hydrogen at position 5' of capsaicin with 6'',7''-dihydrocapsaicin. It is isolated from the dried fruits of Capsicum annuum and exhibits antioxidant activity.


name: Other Stimulant Use, Unspecified with Stimulant-Induced Psychotic Disorder with Hallucinations

description: Evidence of other stimulant use, unspecified with stimulant-induced psychotic disorder with hallucinations not specified elsewhere.


Acute Sarcopenia

description: Sarcopenia associated with a significant physiological stressor event, including acute illness, surgery, or trauma.


name: Asperger syndrome, X-linked, susceptibility to, 2


name: Acute Anteroseptal Myocardial Infarction by ECG Finding

description: An electrocardiographic finding of pathologic Q waves with accompanying ST elevation in leads V1 through V4, which is suggestive of acute myocardial infarction of the anteroseptal wall of the left ventricle. (CDISC)


name: Acute Myocardial Infarction by ECG Finding

description: An electrocardiographic finding showing a current of injury with ST elevation. No specification is provided for localization. (CDISC)


name: Acute Inferior Myocardial Infarction by ECG Finding

description: An electrocardiographic finding of pathologic Q waves with accompanying ST elevation in leads III, aVF and often II, which is suggestive of acute myocardial infarction of the inferior wall of the left ventricle. (CDISC)


name: Acute Posterior Myocardial Infarction by ECG Finding

description: An electrocardiographic finding in leads V1 or V2 of an initial R wave duration greater than or equal to 40 ms, R wave greater than S wave, upright T wave, with accompanying ST elevation, which is suggestive of acute myocardial infarction of the posterior wall of the left ventricle. Evidence of inferior or lateral myocardial infarction is usually also present. (CDISC)


name: Acute Septal Myocardial Infarction by ECG Finding

description: An electrocardiographic finding of pathologic Q waves with accompanying ST elevation in leads V1, V2 and often V3, which is suggestive of acute myocardial infarction of the intraventricular septum. (CDISC)


name: Acute Anterolateral Myocardial Infarction by ECG Finding

description: An electrocardiographic finding of pathologic Q waves with accompanying ST elevation in leads V3 through V6, which is suggestive of acute myocardial infarction of the anterolateral wall of the left ventricle. (CDISC)


name: Acute Right Ventricular Myocardial Infarction by ECG Finding

description: An electrocardiographic finding in leads V1 or V2 of an initial R wave duration greater than or equal to 40 ms, R wave greater than S wave, upright T wave, with accompanying ST elevation, which is suggestive of acute myocardial infarction of the ventricular wall of the left ventricle. Evidence of inferior or lateral myocardial infarction is usually also present. (CDISC)


name: Acute ST Elevation Myocardial Infarction by ECG Finding

description: An electrocardiographic finding of an acute myocardial infarction which produces characteristic elevations of the ST segment of the ECG.


name: Acute Lateral Myocardial Infarction by ECG Finding

description: An electrocardiographic finding of pathologic Q waves with accompanying ST elevation in leads V5, V6, I and aVL, which is suggestive of acute myocardial infarction of the lateral wall of the left ventricle. (CDISC)


name: Acute High Lateral Myocardial Infarction by ECG Finding

description: An electrocardiographic finding of pathologic Q waves with accompanying ST elevation in leads I and aVL, which is suggestive of acute myocardial infarction of the high lateral wall of the left ventricle. (CDISC)


name: Acute Anterior Myocardial Infarction by ECG Finding

description: An electrocardiographic finding of pathologic Q waves with accompanying ST elevation in leads V3 and V4, which is suggestive of acute myocardial infarction of the anterior wall of the left ventricle. (CDISC)


Val-Asp

A dipeptide formed from L-valine and L-aspartic acid residues.


Grade 3 Pain, CTCAE

description: Severe pain; limiting self care ADL


pT1b TNM Finding

description: A pathologic primary tumor TNM finding. The definition of pT1b finding depends on the particular type of cancer that it refers to; for example, for breast cancer, pT1b finding is defined as follows: cancer with tumor size more than 0.5 cm, but not more than 1.0 cm in greatest dimension; for lung cancer, pT1b finding is defined as follows: cancer with a tumor size more than 2 cm but 3 cm or less in greatest dimension, surrounded by lung or visceral pleura and without bronchoscopic evidence of invasion more proximal than the lobar bronchus (i.e., not in the main bronchus). (from AJCC 7th Ed.)


pT1 TNM Finding

description: A pathologic primary tumor TNM finding.  The definition of pT1 finding depends on the particular type of cancer that it refers to; for example, for breast cancer, pT1 finding is defined as follows: cancer with tumor size 2.0 cm or less in greatest dimension; for colorectal cancer, pT1 stage finding is defined as follows: cancer with invasion into the submucosa. (from AJCC 6th and 7th Eds.)


pT1c TNM Finding

description: A pathologic primary tumor TNM finding. The definition of pT1c  finding depends on the particular type of cancer that it refers to; for example, for breast cancer, pT1c finding is defined as follows: cancer with tumor size more than 1.0 cm, but not more than 2.0 cm in greatest dimension; for fallopian tube cancer, pT1c finding is defined as follows: cancer with tumor limited to one or both tubes with extension onto or through the tubal serosa, or with malignant cells in ascites or peritoneal washings. (from AJCC 7th Ed.)


pT1a TNM Finding

description: A pathologic primary tumor TNM finding.  The definition of pT1a finding depends on the particular type of cancer that it refers to; for example, for breast cancer, pT1a finding is defined as follows: cancer with tumor size more than 0.1 cm, but not more than 0.5 cm in greatest dimension; for lung cancer, pT1a finding is defined as follows: cancer with a tumor size of 2 cm or less in greatest dimension, surrounded by lung or visceral pleura and without bronchoscopic evidence of invasion more proximal than the lobar bronchus (i.e., not in the main bronchus). The uncommon superficial tumor of any size with its invasive component limited to the bronchial wall, which may extend proximal to the main bronchus, is also classified as T1a. (from AJCC 7th Ed.)


2-hydroxytridecanoic acid

A 2-hydroxy fatty acid that is tridecanoic acid substituted by  a hydroxy group at position 2.


Diffuse Low Grade Glioma, FGFR1-Mutant

description: Diffuse low-grade glioma characterized by FGFR1 gene mutations, an internal tandem duplication within the FGFR1 gene or the presence of an FGFR1 fusion gene.


An unsaturated fatty acyl-CoA that results from the formal condensation of the thiol group of coenzyme A with the carboxy group of (2E,9Z,12Z,15Z,18Z,21Z)-tetracosahexaenoic acid.


name: Grade 1 Ventricular Arrhythmia NOS, CTCAE


name: Peripheral T-Cell Lymphoma, not Classified, Spleen

description: Evidence of unclassified peripheral T-cell lymphoma in the spleen.


Grade 4 Premature Delivery, CTCAE

description: Delivery of a liveborn infant at 24 weeks of gestation or less


2-hydroxy-5-methyl-cis,cis-muconic acid

A dicarboxylic acid that is cis,cis-muconic acid in which the hydrogens at positions 2 and 5 are substituted by hydroxy and methyl groups, respectively.


Stage IV Rectosigmoid Cancer AJCC v7

description: Stage IV includes: IVA: (Any T, Any N, M1a); IVB: (Any T, Any N, M1b).  M1a: Metastasis confined to one organ or site (e.g., liver, lung, ovary, nonregional node).  M1b: Metastases in more than one organ/site or the peritoneum. (AJCC 7th ed.)


alliin zwitterion

An L-alpha-amino acid zwitterion that is allin in which a proton has been transferred from the carboxy group to the amino group. It is the major species at pH 7.3.


Astler-Coller B1 Rectal Carcinoma

description: Stage I includes: (T1, N0, M0) and (T2, N0, M0).  T1: Tumor invades submucosa.  T2: Tumor invades muscularis propria. (AJCC 6th ed.)


Postprocedural respiratory disorders

description: A respiratory disorder occurring as a consequence of a procedure.


beta-L-gulofuranose

An L-gulofuranose in which the anomeric centre has beta- configuration.


name: Grade 2 Salivary Duct Intra-Operative Injury, CTCAE


name: Salivary Duct Intra-Operative Injury, CTCAE


name: Grade 4 Salivary Duct Intra-Operative Injury, CTCAE


name: Grade 3 Salivary Duct Intra-Operative Injury, CTCAE


name: Grade 1 Salivary Duct Intra-Operative Injury, CTCAE


An L-alpha-amino acid zwitterion that results from the transfer of a proton from the carboxylic acid group to the alpha-amino group of N(3)-fumaramoyl-(S)-2,3-diaminopropanoic acid; major species at pH 7.3.


pluronic P-123

A triblock copolymer composed of a central hydrophobic chain of poly(propylene oxide) (70 units) flanked by two hydrophilic chains of poly(ethylene oxide) (20 units each). A polymer with the formula HO[CH2CH2O]2O[CH2CH(CH3)O]70[CH2CH2O]2OH.


triblock copolymer

A polymer composed of three blocks of homopolymers in a linear sequence.